Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Obesity drug helps unlock clues about cancer

05.02.2007
An approved drug for fighting obesity is helping scientists at Wake Forest University School of Medicine uncover clues about how to stop the growth of cancerous tumors.

"Our discovery makes an exciting treatment target because theoretically you don't have to worry about harming nearby healthy tissue," said senior researcher Steven J. Kridel, Ph.D., an assistant professor in the Department of Cancer Biology.

In the current issue of Cancer Research, Kridel and colleagues are the first to report that a tubular network within cells, known as the endoplasmic reticulum (ER), is regulated by an enzyme that is tightly linked to tumor growth and development.

"When the ER cannot do its job properly, there's a series of events that gets turned on that can lead to cell suicide or death," said Kridel.

... more about:
»Cancer »Kridel »acid »enzyme »synthase »tumor cells

The research showed that an enzyme known as fatty acid synthase is vital for the ER to do its job. Blocking this enzyme, which makes fat in cells, has been shown to prevent tumor cell growth and to promote cell death.

"No one had made connection before between fatty acid synthase and the function of the ER in tumor cells," said Kridel. "This is the first to show that fatty acid synthesis is important in maintaining ER function and keeping tumor cells alive."

The researchers started the work five years ago when they analyzed prostate cancer cells to see which proteins and enzymes were expressed at high levels. Their hope was that treatments that reduced those levels could also stop tumor growth.

"We found that fatty acid synthase is expressed at high levels in tumor cells, but is fairly absent in normal cells," said Kridel. "Other researchers had made similar findings in other types of cancer cells, so we decided to follow up because it looked promising.

"We then made the surprising finding that OrlistatTM, a drug approved by the FDA to treat obesity, can block the function of fatty acid synthase, prevent tumor cell growth and promote tumor cell death."

Finding out exactly how the drug worked was the next step, so that better treatments could be developed. While effective in mice, Olistat's current formulation cannot be given to humans as a cancer treatment because it acts only in the digestive tract.

In the current study, Kridel and colleagues treated prostate, colon and cervical cancer cells in the laboratory with Olistat and two other agents to understand why blocking fatty acid synthase induces cell death.

"Our goal was to understand how fatty acid synthase contributes to tumor growth," said Kridel. "This might provide an explanation for why this enzyme is expressed at high levels."

Now that the scientists understand that the ER is involved -- and that inhibiting fatty acid synthase can impair its function -- they are working to develop new treatments for cancer therapy.

They are exploring the possibility of using existing FDA-approved drugs, as well as developing new drugs. They've already determined that the structure of Orlistat bound to fatty acid synthase, which is the first step in developing similar agents that could be used in humans.

"Our latest findings that connect fatty acid synthase and ER function gives us a better understanding about how the drug kills tumor cells and give us clues to make better drugs," said Kridel. "For any drugs we develop, we'll need to show that they impair the function of the ER."

Karen Richardson | EurekAlert!
Further information:
http://www.wfubmc.edu

Further reports about: Cancer Kridel acid enzyme synthase tumor cells

More articles from Life Sciences:

nachricht Discovery of a Key Regulatory Gene in Cardiac Valve Formation
24.05.2017 | Universität Basel

nachricht Carcinogenic soot particles from GDI engines
24.05.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

Physicists discover mechanism behind granular capillary effect

24.05.2017 | Physics and Astronomy

Measured for the first time: Direction of light waves changed by quantum effect

24.05.2017 | Physics and Astronomy

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>